Synonym
ML-162; ML162; ML 162
IUPAC/Chemical Name
2-chloro-N-(3-chloro-4-methoxyphenyl)-N-(2-oxo-2-(phenethylamino)-1-(thiophen-2-yl)ethyl)acetamide
InChi Key
UNVKYJSNMVDZJE-UHFFFAOYSA-N
InChi Code
InChI=1S/C23H22Cl2N2O3S/c1-30-19-10-9-17(14-18(19)25)27(21(28)15-24)22(20-8-5-13-31-20)23(29)26-12-11-16-6-3-2-4-7-16/h2-10,13-14,22H,11-12,15H2,1H3,(H,26,29)
SMILES Code
O=C(NCCC1=CC=CC=C1)C(C2=CC=CS2)N(C3=CC=C(C(Cl)=C3)OC)C(CCl)=O
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
|
Solvent |
mg/mL |
mM |
comments |
| Solubility |
| DMF |
10.0 |
20.95 |
|
| DMSO |
25.0 |
52.37 |
|
| Ethanol |
1.0 |
2.09 |
|
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.
Preparing Stock Solutions
The following data is based on the
product
molecular weight
477.40
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Shin D, Kim EH, Lee J, Roh JL. Nrf2 inhibition reverses resistance to GPX4
inhibitor-induced ferroptosis in head and neck cancer. Free Radic Biol Med. 2018
Dec;129:454-462. doi: 10.1016/j.freeradbiomed.2018.10.426. Epub 2018 Oct 16.
PMID: 30339884.
2: Frye WJE, Huff LM, González Dalmasy JM, Salazar P, Carter RM, Gensler RT,
Esposito D, Robey RW, Ambudkar SV, Gottesman MM. The multidrug resistance
transporter P-glycoprotein confers resistance to ferroptosis inducers. Cancer
Drug Resist. 2023 Jul 27;6(6):468-480. doi: 10.20517/cdr.2023.29. PMID:
37840856; PMCID: PMC10571053.
3: Caro AA, Barrett D, Garcia C, Northington W, Pinkney J, Shuja R, Stovall H.
CYP2E1 overexpression protects COS-7 cancer cells against ferroptosis. Res Sq
[Preprint]. 2023 Mar 22:rs.3.rs-2702878. doi: 10.21203/rs.3.rs-2702878/v1. PMID:
36993697; PMCID: PMC10055644.
4: Zhu L, Hu S, Yan X, Zeng Q, Zhang B, Jiang L, Yao SQ, Ge J. Ugi reaction-
assisted assembly of covalent PROTACs against glutathione peroxidase 4. Bioorg
Chem. 2023 May;134:106461. doi: 10.1016/j.bioorg.2023.106461. Epub 2023 Mar 11.
PMID: 36924654.
5: Frye WJE, Huff LM, Dalmasy JMG, Salazar P, Carter RM, Gensler RT, Esposito D,
Robey RW, Ambudkar SV, Gottesman MM. The Multidrug Resistance Transporter
P-glycoprotein Confers Resistance to Ferroptosis Inducers. bioRxiv [Preprint].
2023 Feb 23:2023.02.23.529736. doi: 10.1101/2023.02.23.529736. Update in: Cancer
Drug Resist. 2023 Jul 27;6(6):468-480. doi: 10.20517/cdr.2023.29. PMID:
36945397; PMCID: PMC10028811.
6: Wagener N, Hardt S, Pumberger M, Schömig F. Cartilage Destruction by
Hemophilic Arthropathy Can Be Prevented by Inhibition of the Ferroptosis Pathway
in Human Chondrocytes. J Clin Med. 2024 Jan 18;13(2):559. doi:
10.3390/jcm13020559. PMID: 38256694; PMCID: PMC10816407.
